Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Epigallocatechin gallate (EGCG), a major catechin found in green tea, has attracted scientific attention for its potential anti-aging properties. The interest is largely based on laboratory and animal studies demonstrating its antioxidant, anti-inflammatory, and cellular protective effects. EGCG is known to scavenge free radicals, reduce oxidative stress, and modulate signaling pathways (such as AMPK and mTOR) associated with cellular aging and longevity. Some in vitro and animal research suggests that EGCG may enhance lifespan and delay the onset of age-related diseases by protecting against DNA damage, improving mitochondrial function, and reducing chronic inflammation.

However, direct evidence in humans is limited. While population studies link high green tea consumption with lower rates of age-related diseases (such as cardiovascular disease and neurodegeneration), these findings are observational and may be influenced by other factors. Clinical trials examining EGCG supplementation in humans have shown modest benefits in biomarkers related to aging (e.g., reduced oxidative stress and inflammation), but effects on actual lifespan or broad aging outcomes remain unproven. No large, long-term randomized controlled trials have demonstrated that EGCG supplementation can significantly delay aging or extend healthy lifespan in humans.

In summary, while preclinical research provides a scientific rationale for EGCG’s potential role in aging prevention, clinical evidence in humans is still emerging and remains inconclusive. Thus, EGCG's use for aging prevention is supported primarily by promising—but not definitive—scientific evidence.

More about epigallocatechin gallate (EGCG)
More about Aging (prevention)

Other ingredients used for Aging (prevention)

Other health conditions supported by epigallocatechin gallate (EGCG)

Products containing epigallocatechin gallate (EGCG)